These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 19433129

  • 1. History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia.
    Pae CU, Masand PS, Marks DM, Krulewicz S, Peindl K, Mannelli P, Patkar AA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug 31; 33(6):996-1002. PubMed ID: 19433129
    [Abstract] [Full Text] [Related]

  • 2. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
    Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA.
    World J Biol Psychiatry; 2009 Aug 31; 10(4 Pt 2):435-41. PubMed ID: 19382010
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 31; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 4. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug 31; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C, Mangano R, Zhang J, Dahl AA, Lepola U, Sjödin I, Emilien G, SAD 388 Study Group.
    Hum Psychopharmacol; 2004 Aug 31; 19(6):387-96. PubMed ID: 15303242
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug 31; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 7. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Aug 31; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 8. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
    Gottlieb SS, Kop WJ, Thomas SA, Katzen S, Vesely MR, Greenberg N, Marshall J, Cines M, Minshall S.
    Am Heart J; 2007 May 31; 153(5):868-73. PubMed ID: 17452166
    [Abstract] [Full Text] [Related]

  • 9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 31; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.
    Arthritis Rheum; 2010 Jan 31; 62(1):291-300. PubMed ID: 20039417
    [Abstract] [Full Text] [Related]

  • 11. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
    Pollack MH, Meoni P, Otto MW, Simon N, Hackett D.
    J Clin Psychopharmacol; 2003 Jun 31; 23(3):250-9. PubMed ID: 12826987
    [Abstract] [Full Text] [Related]

  • 12. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec 31; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group.
    Arthritis Rheum; 2009 Jan 31; 60(1):299-309. PubMed ID: 19116896
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J, Aubin V.
    Encephale; 2001 Jan 31; 27(1):71-81. PubMed ID: 11294041
    [Abstract] [Full Text] [Related]

  • 15. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 Jan 31; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 16. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 31; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1992 Feb 31; 53 Suppl():52-6. PubMed ID: 1531826
    [Abstract] [Full Text] [Related]

  • 19. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun 31; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb 31; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.